Activation and modulation of cardiac poly-adenosine diphosphate ribose polymerase activity in a rat model of brain

John G Brain1, Anthony J Rostron, John H Dark

  • 1Applied Immunobiology and Transplantation Research Group, Institute of Cellular Medicine, The Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, United Kingdom. j.g.brain@ncl.ac.uk

Transplantation
|May 14, 2008
PubMed

Insights

Brain death causes DNA damage, activating poly-adenosine diphosphate ribose polymerase (PARP). Donor resuscitation with noradrenaline or vasopressin reduced PARP activation, mitigating cardiac cell death and improving transplant outcomes.

Area of Science:

  • Transplantation immunology
  • Cellular signaling pathways
  • Organ preservation

Background:

  • DNA damage during organ transplantation can activate poly-adenosine diphosphate ribose polymerase (PARP).
  • Excessive PARylation of nuclear proteins by PARP can lead to cell death, impairing transplanted organ function.
  • Brain death in donors is a significant factor affecting graft quality and post-transplant outcomes.

Purpose of the Study:

  • To investigate PARP activation profiles in a rat brain death model.
  • To determine if donor resuscitation strategies can ameliorate PARP-induced cell death mechanisms.
  • To assess the impact of chronic hypotension on PARP activation and cardiac function in potential transplant donors.

Main Methods:

  • Utilized a rat model of induced brain death.
  • Quantified the expression of PAR-linked nuclear proteins in cardiac myocytes.
  • Administered noradrenaline or vasopressin to normalize blood pressure in hypotensive donors.

Main Results:

  • Brain death induction significantly increased PAR-linked protein expression in cardiac myocytes.
  • Donor resuscitation with noradrenaline or vasopressin markedly reduced PAR expression, even below baseline levels.
  • These findings indicate a direct link between hypotension post-brain death and PARP activation.

Conclusions:

  • Chronic hypotension following donor brain death activates PARP, potentially limiting cardiac allograft function.
  • Early intervention through appropriate donor resuscitation can mitigate this PARP-mediated graft damage.
  • Optimizing donor management strategies is crucial for improving transplant success rates.

Related Concept Videos